Microvascular angina – an abstruse path to diagnose and to treat – a review of literature
DOI:
https://doi.org/10.12775/JEHS.2024.51.015Keywords
microvascular angina, coronary microvascular dysfunction, cardiac syndrome X, microcirculation, chronic coronary syndromeAbstract
Introduction: Chronic coronary syndrome is predominantly related to the atherosclerotic obstruction of the coronary artery or arteries. However, this phenomenon is not the only causative factor in this disease. It is usually forgotten, that there is a possibility of ischemia of the cardiac muscle with no obstruction found in the main vessel. The trigger of such pathology might be underlying in the microcirculatory system and the inappropriate dilation or constriction of those small vessels, which results in insufficient blood supply to the cardiomyocytes, similarly to the typical obstructive coronary artery disease. In this article we are willing to show that such dysfunction poses a great danger to the health and life and therefore we should be able to properly diagnose and treat it.
Purpose of the work: The aim of this review of up-to-date literature is to raise awareness among both doctors and patients about the phenomenon of coronary artery disease but with no significant obstruction in the vessels supplying the cardiac muscle. The common cause of such condition is coronary microvascular dysfunction, that leads to a disease called microvascular angina. Our purpose was to reveal, how dangerous to the health of the patients this could be and therefore how essential it is to provide a proper diagnose and management. In addition, we have noticed a need for a summary of what has already been discovered on this topic, available therapeutic methods and future perspectives.
References
Heart Disease Facts | CdC.gov. Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/facts.htm. Published May 15, 2023.
Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9). doi:10.1161/cir.0000000000001168.
Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. International Journal of Cardiology. 2018;250:16-20. doi:10.1016/j.ijcard.2017.08.068.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2019;41(3):407-477. doi:10.1093/eurheartj/ehz425.
Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. European Heart Journal. 2012;33(22):2771-2783. doi:10.1093/eurheartj/ehs246.
Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal. 2011;33(6):734-744. doi:10.1093/eurheartj/ehr331.
Gulati M, Cooper‐DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. Archives of Internal Medicine. 2009;169(9):843. doi:10.1001/archinternmed.2009.50.
The Copenhagen city heart study. European Heart Journal Supplements. 2001;3:H1-H83. doi:10.1016/s1520-765x(01)90110-5.
Patel B, Fisher M. Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma. Pharmacology & Therapeutics. 2010;127(2):131-147. doi:10.1016/j.pharmthera.2010.04.014.
Gryglewska B. The microcirculation and hypertension. Gryglewska | Arterial Hypertension. https://journals.viamedica.pl/arterial_hypertension/article/view/12857. Published 2001.
Civieri G, Kerkhof PLM, Montisci R, Iliceto S, Tona F. Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation. Atherosclerosis. 2023;384:117276. doi:10.1016/j.atherosclerosis.2023.117276.
Sechtem U, Brown DL, Godo S, Lanza GA, Shimokawa H, Sidik N. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease). Cardiovascular Research. 2020;116(4):771-786. doi:10.1093/cvr/cvaa005.
Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eurointervention. 2021;16(13):1049-1069. doi:10.4244/eijy20m07_01.
Ford T, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina. Journal of the American College of Cardiology. 2018;72(23):2841-2855. doi:10.1016/j.jacc.2018.09.006.
Dedić S, Bošković N, Giga V, et al. Haemodynamic indicators of arteriolar dysregulation during combined hyperventilation and exercise test in patients with ANOCA (SESPASM). European Heart Journal. 2022;43(Supplement_2). doi:10.1093/eurheartj/ehac544.082.
Ullrich-Daub H, Daub S, Olschewski M, Münzel T, Gori T. Diseases of the coronary microcirculation: diagnosis and treatment. Deutsches Arzteblatt International. November 2023. doi:10.3238/arztebl.m2023.0205.
Sütsch G, Oechslin E, Mayer I, Hess OM. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. International Journal of Cardiology. 1995;52(2):135-143. doi:10.1016/0167-5273(95)02458-9.
Togni M, Vigorito F, Windecker S, et al. Does the Β-Blocker Nebivolol increase coronary flow reserve? Cardiovascular Drugs and Therapy. 2007;21(2):99-108. doi:10.1007/s10557-006-0494-7.
Mehta PK, Goykhman P, Thomson L, et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC: Cardiovascular Imaging. 2011;4(5):514-522. doi:10.1016/j.jcmg.2011.03.007.
Eriksson BE, Tyni-Lenné R, Svedenhag J, et al. Physical training in Syndrome X. Journal of the American College of Cardiology. 2000;36(5):1619-1625. doi:10.1016/s0735-1097(00)00931-1.
Denardo SJ, Wen X, Handberg EM, et al. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: A Women’s Ischemia Syndrome Evaluation (WISE) Ancillary study. Clinical Cardiology. 2011;34(8):483-487. doi:10.1002/clc.20935.
Yoo SY, Song SG, Lee J, et al. Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. Cardiovascular Therapeutics. 2013;31(3):179-185. doi:10.1111/j.1755-5922.2012.00312.x.
Shin E, Lee J, Yoo SY, et al. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. Heart. 2014;100(19):1531-1536. doi:10.1136/heartjnl-2014-305986.
Neglia D, Fommei E, Varela-Carver A, et al. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. Journal of Hypertension. 2011;29(2):364-372. doi:10.1097/hjh.0b013e328340a08e.
Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. The New England Journal of Medicine. 2010;362(10):886-895. doi:10.1056/nejmoa0907272.
Banerjee D, Sabe SA, Xing H, et al. Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis. The Journal of Thoracic and Cardiovascular Surgery. 2023;166(6):e535-e550. doi:10.1016/j.jtcvs.2023.08.017.
Case BC, Merdler I, Medranda GA, et al. Understanding Patient Characteristics and Coronary Microvasculature: Early Insights from the Coronary Microvascular Disease Registry. The American Journal of Cardiology. 2023;205:97-103. doi:10.1016/j.amjcard.2023.07.159.
Schindler TH, Dilsizian V. Coronary microvascular dysfunction. JACC: Cardiovascular Imaging. 2020;13(1):140-155. doi:10.1016/j.jcmg.2018.11.036.
Kuruvilla S, Kramer CM. Coronary microvascular dysfunction in women: an overview of diagnostic strategies. Expert Review of Cardiovascular Therapy. 2013;11(11):1515-1525. doi:10.1586/14779072.2013.833854.
Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia. Journal of the American College of Cardiology. 2010;55(25):2825-2832. doi:10.1016/j.jacc.2010.01.054.
Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia. Archives of General Psychiatry. 2006;63(8):874. doi:10.1001/archpsyc.63.8.874.
Pries AR, Reglin B. Coronary microcirculatory pathophysiology: can we afford it to remain a black box? European Heart Journal. February 2016:ehv760. doi:10.1093/eurheartj/ehv760.
Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23(2):168-175. doi:10.1161/01.atv.0000051384.43104.fc.
Sara JD, Toya T, Ahmad A, et al. Mental stress and its effects on vascular health. Mayo Clinic Proceedings. 2022;97(5):951-990. doi:10.1016/j.mayocp.2022.02.004.
Williams JK, Kaplan JR, Manuck SB. Effects of psychosocial stress on endothelium-mediated dilation of atherosclerotic arteries in cynomolgus monkeys. Journal of Clinical Investigation. 1993;92(4):1819-1823. doi:10.1172/jci116772.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Urszula Matuszewska, Aleksandra Nykowska, Katarzyna Beutler, Bartosz Bijata, Dawid Burek, Aleksandra Paszkowska, Aleksandra Kujawa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 323
Number of citations: 0